Ebru Aydin

607 total citations
22 papers, 388 citations indexed

About

Ebru Aydin is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Ebru Aydin has authored 22 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Ebru Aydin's work include Immune Cell Function and Interaction (7 papers), Immune cells in cancer (6 papers) and Acute Myeloid Leukemia Research (3 papers). Ebru Aydin is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immune cells in cancer (6 papers) and Acute Myeloid Leukemia Research (3 papers). Ebru Aydin collaborates with scholars based in Sweden, Germany and Türkiye. Ebru Aydin's co-authors include Kristoffer Hellstrand, Anna Martner, Faisal Hayat Nazir, Fredrik B. Thorén, Johan Aurelius, Brianna Lenox, Anders Ståhlberg, Priscilla K. Brastianos, Mohan Bala and Roberta Kiffin and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ebru Aydin

22 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ebru Aydin Sweden 12 191 139 90 47 47 22 388
Sabine Olivier Belgium 7 156 0.8× 203 1.5× 94 1.0× 60 1.3× 91 1.9× 7 423
Sen Zhang China 10 121 0.6× 140 1.0× 62 0.7× 18 0.4× 40 0.9× 33 364
Jia Gu China 12 99 0.5× 184 1.3× 116 1.3× 36 0.8× 136 2.9× 33 428
Hong Im Kim United States 10 62 0.3× 182 1.3× 60 0.7× 95 2.0× 51 1.1× 15 376
Taro Yumioka Japan 9 163 0.9× 181 1.3× 130 1.4× 23 0.5× 64 1.4× 9 381
Bingmu Fang China 9 98 0.5× 136 1.0× 141 1.6× 15 0.3× 83 1.8× 20 339
Melanie Hofmann Germany 9 124 0.6× 162 1.2× 53 0.6× 45 1.0× 52 1.1× 16 375
Elena Kotsaki Greece 5 203 1.1× 192 1.4× 68 0.8× 25 0.5× 127 2.7× 6 456

Countries citing papers authored by Ebru Aydin

Since Specialization
Citations

This map shows the geographic impact of Ebru Aydin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Aydin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Aydin more than expected).

Fields of papers citing papers by Ebru Aydin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebru Aydin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Aydin. The network helps show where Ebru Aydin may publish in the future.

Co-authorship network of co-authors of Ebru Aydin

This figure shows the co-authorship network connecting the top 25 collaborators of Ebru Aydin. A scholar is included among the top collaborators of Ebru Aydin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebru Aydin. Ebru Aydin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydin, Ebru, Roberta Kiffin, Johan Bourghardt Fagman, et al.. (2024). Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer. Cancer Research Communications. 4(4). 1135–1149. 2 indexed citations
4.
Akhiani, Ali A., Roberta Kiffin, Ebru Aydin, et al.. (2020). Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species. Cancer Immunology Research. 8(12). 1532–1541. 14 indexed citations
5.
Kilchert, Cornelia, Svenja Hester, Ebru Aydin, et al.. (2020). System-wide analyses of the fission yeast poly(A) + RNA interactome reveal insights into organization and function of RNA–protein complexes. Genome Research. 30(7). 1012–1026. 6 indexed citations
6.
Aydin, Ebru, et al.. (2019). Real-world data analysis of ovarian cancer (OC) maintenance utilization among maintenance eligible patients.. Journal of Clinical Oncology. 37(15_suppl). 5579–5579. 6 indexed citations
7.
Kiffin, Roberta, Ebru Aydin, Malin S. Nilsson, et al.. (2019). Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis. OncoImmunology. 9(1). 1684126–1684126. 7 indexed citations
8.
Ratner, Elena, et al.. (2019). Increased risk of brain metastases in ovarian cancer patients with BRCA mutations. Gynecologic Oncology. 153(3). 568–573. 31 indexed citations
9.
Aydin, Ebru, et al.. (2019). Comparison of Gross Motor Skills of 8-10 Years Old Students Active in Different Sport Branches. Asian Journal of Education and Training. 5(4). 582–588. 1 indexed citations
10.
Aydin, Ebru, et al.. (2019). Recurrence of ovarian cancer in BRCAwt patients without maintenance therapy: Real-world evidence.. Journal of Clinical Oncology. 37(15_suppl). 5547–5547. 2 indexed citations
11.
Nilsson, Malin S., Karin Christenson, Ebru Aydin, et al.. (2018). Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia. Cancer Immunology Research. 6(9). 1110–1119. 8 indexed citations
12.
Aydin, Ebru, et al.. (2018). NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease. Oncogene. 38(9). 1534–1543. 24 indexed citations
13.
Kiffin, Roberta, Malin S. Nilsson, Johan Aurelius, et al.. (2018). Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2. Frontiers in Oncology. 8. 218–218. 25 indexed citations
14.
Aydin, Ebru. (2017). Determination of self-care power of hemodialysis patients. New Trends and Issues Proceedings on Humanities and Social Sciences. 4(2). 292–300. 1 indexed citations
15.
Aydin, Ebru, et al.. (2017). Role of NOX2-Derived Reactive Oxygen Species in NK Cell–Mediated Control of Murine Melanoma Metastasis. Cancer Immunology Research. 5(9). 804–811. 88 indexed citations
16.
Gomes, Ana, et al.. (2016). Sirtuin1 (SIRT1) in the Acetylation of Downstream Target Proteins. Methods in molecular biology. 1436. 169–188. 26 indexed citations
17.
Aydin, Ebru, Willem Jonker, Lijuan Hu, et al.. (2015). A hypomorphic Cbx3 allele causes prenatal growth restriction and perinatal energy homeostasis defects. Journal of Biosciences. 40(2). 325–338. 6 indexed citations
18.
Aydin, Ebru, Ozlen Saglam, Ozlem Guzeloglu‐Kayisli, et al.. (2014). mRNA-Binding Protein TIA-1 Reduces Cytokine Expression in Human Endometrial Stromal Cells and Is Down-Regulated in Ectopic Endometrium. The Journal of Clinical Endocrinology & Metabolism. 99(12). E2610–E2619. 11 indexed citations
19.
Darcan, Cihan & Ebru Aydin. (2012). furmutation increases the survival time ofEscherichia coliunder photooxidative stress in aquatic environments. Acta Biologica Hungarica. 63(3). 399–409. 5 indexed citations
20.
Yaylı, Nurettin, et al.. (2006). Sesquiterpene lactones from Centaurea helenioides Boiss. TURKISH JOURNAL OF CHEMISTRY. 30(2). 229–233. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026